Neuroprotective Drugs Market Report

China Neuroprotective Drugs Industry Market Research Report 2023-2029

  • POSTDATE：Oct 14, 2023
  • PAGES：147
  • REPORT CODE：GMM1852644
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Neuroprotective Drugs industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • NeuroVive Pharmaceutical (Sweden)

    • Ceregene (USA)

    • Neuren Pharmaceuticals (Australia)

    • Genervon Biopharmaceuticals (Canada)

    • Allon therapeutics (Canada)

    • Bionure Inc (USA)

    By Type:

    • Anti-inflammatory

    • Cholinesterase Inhibitors

    • Others

    By Application:

    • Alzheimer's disease

    • Parkinson's disease

    • Others

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Neuroprotective Drugs Market Overview 2018-2029

    • 1.1 China Neuroprotective Drugs Industry Development Overview

    • 1.2 China Neuroprotective Drugs Industry Development History

    • 1.3 China Neuroprotective Drugs Industry Market Size (2018-2029)

    • 1.4 China Neuroprotective Drugs Market Analysis by Type from Production Side

      • 1.4.1 China Neuroprotective Drugs Production Volume, Production Value and Growth Rate of Anti-inflammatory (2018-2029)

      • 1.4.2 China Neuroprotective Drugs Production Volume, Production Value and Growth Rate of Cholinesterase Inhibitors (2018-2029)

      • 1.4.3 China Neuroprotective Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • 1.5 China Neuroprotective Drugs Market Analysis by Application from Consumption End

      • 1.5.1 China Neuroprotective Drugs Sales Volume, Sales Value and Growth Rate of Alzheimer's disease (2018-2029)

      • 1.5.2 China Neuroprotective Drugs Sales Volume, Sales Value and Growth Rate of Parkinson's disease (2018-2029)

      • 1.5.3 China Neuroprotective Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • 1.6 China Neuroprotective Drugs Market Analysis by Region

      • 1.6.1 North China Neuroprotective Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Neuroprotective Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Neuroprotective Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Neuroprotective Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Neuroprotective Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Neuroprotective Drugs Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Neuroprotective Drugs Market Size and Growth Rate from 2018-2029

    Chapter 2 China Neuroprotective Drugs Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Neuroprotective Drugs Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Neuroprotective Drugs Market Status and Competition Analysis in 2023

      • 2.2.3 China Neuroprotective Drugs Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Neuroprotective Drugs Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Neuroprotective Drugs Industry Development

    Chapter 3 Neuroprotective DrugsIndustry Chain Analysis

    • 3.1 Neuroprotective Drugs Industry Chain

    • 3.2 Neuroprotective Drugs Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Neuroprotective Drugs Market

    • 3.3 Neuroprotective Drugs Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Neuroprotective Drugs Market

    Chapter 4 China Neuroprotective Drugs Market, by Type

    • 4.1 China Neuroprotective Drugs Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Neuroprotective Drugs Total Production Volume and Growth Rate from Production Side

    • 4.5 China Neuroprotective Drugs Production Volume and Growth Rate, by Type

      • 4.5.1 China Neuroprotective Drugs Production Volume and Growth Rate of Anti-inflammatory

      • 4.5.2 China Neuroprotective Drugs Production Volume and Growth Rate of Cholinesterase Inhibitors

      • 4.5.3 China Neuroprotective Drugs Production Volume and Growth Rate of Others

    Chapter 5 China Neuroprotective Drugs Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Neuroprotective Drugs Total Market Size and Growth Rate from Consumption End

    • 5.5 China Neuroprotective Drugs Market Size and Growth Rate, by Application

      • 5.5.1 China Neuroprotective Drugs Market Size and Growth Rate of Alzheimer's disease

      • 5.5.2 China Neuroprotective Drugs Market Size and Growth Rate of Parkinson's disease

      • 5.5.3 China Neuroprotective Drugs Market Size and Growth Rate of Others

    Chapter 6 China Neuroprotective Drugs Market, by Region

    • 6.1 China Neuroprotective Drugs Production Volume and Production Value, by Region

    • 6.2 China Neuroprotective Drugs Sales Volume and Sales Value, by Region

    Chapter 7 North China Neuroprotective Drugs Market Analysis

    • 7.1 North China Neuroprotective Drugs Market, by Type

    • 7.2 North China Neuroprotective Drugs Market, by Application

    Chapter 8 Central China Neuroprotective Drugs Market Analysis

    • 8.1 Central China Neuroprotective Drugs Market, by Type

    • 8.2 Central China Neuroprotective Drugs Market, by Application

    Chapter 9 South China Neuroprotective Drugs Market Analysis

    • 9.1 South China Neuroprotective Drugs Market, by Type

    • 9.2 South China Neuroprotective Drugs Market, by Application

    Chapter 10 East China Neuroprotective Drugs Market Analysis

    • 10.1 East China Neuroprotective Drugs Market, by Type

    • 10.2 East China Neuroprotective Drugs Market, by Application

    Chapter 11 Northeast China Neuroprotective Drugs Market Analysis

    • 11.1 Northeast China Neuroprotective Drugs Market, by Type

    • 11.2 Northeast China Neuroprotective Drugs Market, by Application

    Chapter 12 Southwest China Neuroprotective Drugs Market Analysis

    • 12.1 Southwest China Neuroprotective Drugs Market, by Type

    • 12.2 Southwest China Neuroprotective Drugs Market, by Application

    Chapter 13 Northwest China Neuroprotective Drugs Market Analysis

    • 13.1 Northwest China Neuroprotective Drugs Market, by Type

    • 13.2 Northwest China Neuroprotective Drugs Market, by Application

    Chapter 14 Company Profiles

      • 14.1 NeuroVive Pharmaceutical (Sweden)

        • 14.1.1 NeuroVive Pharmaceutical (Sweden) Company Profile

        • 14.1.2 NeuroVive Pharmaceutical (Sweden) Neuroprotective Drugs Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Ceregene (USA)

        • 14.2.1 Ceregene (USA) Company Profile

        • 14.2.2 Ceregene (USA) Neuroprotective Drugs Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Neuren Pharmaceuticals (Australia)

        • 14.3.1 Neuren Pharmaceuticals (Australia) Company Profile

        • 14.3.2 Neuren Pharmaceuticals (Australia) Neuroprotective Drugs Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Genervon Biopharmaceuticals (Canada)

        • 14.4.1 Genervon Biopharmaceuticals (Canada) Company Profile

        • 14.4.2 Genervon Biopharmaceuticals (Canada) Neuroprotective Drugs Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Allon therapeutics (Canada)

        • 14.5.1 Allon therapeutics (Canada) Company Profile

        • 14.5.2 Allon therapeutics (Canada) Neuroprotective Drugs Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Bionure Inc (USA)

        • 14.6.1 Bionure Inc (USA) Company Profile

        • 14.6.2 Bionure Inc (USA) Neuroprotective Drugs Market Performance

        • 14.6.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Neuroprotective Drugs Industry Research Conclusions

    • 15.2 Neuroprotective Drugs Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Neuroprotective Drugs Industry Market Size (2018-2029)

    • Figure China Neuroprotective Drugs Production Volume, Production Value and Growth Rate of Anti-inflammatory (2018-2029)

    • Figure China Neuroprotective Drugs Production Volume, Production Value and Growth Rate of Cholinesterase Inhibitors (2018-2029)

    • Figure China Neuroprotective Drugs Production Volume, Production Value and Growth Rate of Others (2018-2029)

    • Figure China Neuroprotective Drugs Sales Volume, Sales Value and Growth Rate of Alzheimer's disease (2018-2029)

    • Figure China Neuroprotective Drugs Sales Volume, Sales Value and Growth Rate of Parkinson's disease (2018-2029)

    • Figure China Neuroprotective Drugs Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure North China Neuroprotective Drugs Market Size and Growth Rate from 2018-2029

    • Figure Central China Neuroprotective Drugs Market Size and Growth Rate from 2018-2029

    • Figure South China Neuroprotective Drugs Market Size and Growth Rate from 2018-2029

    • Figure East China Neuroprotective Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Neuroprotective Drugs Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Neuroprotective Drugs Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Neuroprotective Drugs Market Size and Growth Rate from 2018-2029

    • Figure Neuroprotective Drugs Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Neuroprotective Drugs Market Share by Type in 2018

    • Figure China Neuroprotective Drugs Market Share by Type in 2023

    • Figure China Neuroprotective Drugs Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Neuroprotective Drugs Production Volume and Growth Rate of Anti-inflammatory (2018-2023)

    • Figure China Neuroprotective Drugs Production Volume and Growth Rate of Cholinesterase Inhibitors (2018-2023)

    • Figure China Neuroprotective Drugs Production Volume and Growth Rate of Others (2018-2023)

    • Figure China Neuroprotective Drugs Market Share by Application in 2018

    • Figure China Neuroprotective Drugs Market Share by Application in 2023

    • Figure China Neuroprotective Drugs Total Market Size and Growth Rate from Consumption End

    • Figure China Neuroprotective Drugs Market Size and Growth Rate of Alzheimer's disease (2018-2023)

    • Figure China Neuroprotective Drugs Market Size and Growth Rate of Parkinson's disease (2018-2023)

    • Figure China Neuroprotective Drugs Market Size and Growth Rate of Others (2018-2023)

    • Table China Neuroprotective Drugs Production Volume by Region (2018-2023)

    • Table China Neuroprotective Drugs Production Volume Share by Region (2018-2023)

    • Figure China Neuroprotective Drugs Production Volume Share by Region (2018-2023)

    • Table China Neuroprotective Drugs Production Value by Region (2018-2023)

    • Table China Neuroprotective Drugs Production Value Share by Region (2018-2023)

    • Figure China Neuroprotective Drugs Production Value Share by Region (2018-2023)

    • Table China Neuroprotective Drugs Sales Volume by Region (2018-2023)

    • Table China Neuroprotective Drugs Sales Volume Share by Region (2018-2023)

    • Figure China Neuroprotective Drugs Sales Volume Share by Region (2018-2023)

    • Table China Neuroprotective Drugs Sales Value by Region (2018-2023)

    • Table China Neuroprotective Drugs Sales Value Share by Region (2018-2023)

    • Figure China Neuroprotective Drugs Sales Value Share by Region (2018-2023)

    • Table North China Neuroprotective Drugs Production Volume by Type (2018-2023)

    • Table North China Neuroprotective Drugs Production Volume Share by Type (2018-2023)

    • Figure North China Neuroprotective Drugs Production Volume Share by Type (2018-2023)

    • Table North China Neuroprotective Drugs Sales Volume by Application (2018-2023)

    • Table North China Neuroprotective Drugs Sales Volume Share by Application (2018-2023)

    • Figure North China Neuroprotective Drugs Sales Volume Share by Application (2018-2023)

    • Table Central China Neuroprotective Drugs Production Volume by Type (2018-2023)

    • Table Central China Neuroprotective Drugs Production Volume Share by Type (2018-2023)

    • Figure Central China Neuroprotective Drugs Production Volume Share by Type (2018-2023)

    • Table Central China Neuroprotective Drugs Sales Volume by Application (2018-2023)

    • Table Central China Neuroprotective Drugs Sales Volume Share by Application (2018-2023)

    • Figure Central China Neuroprotective Drugs Sales Volume Share by Application (2018-2023)

    • Table South China Neuroprotective Drugs Production Volume by Type (2018-2023)

    • Table South China Neuroprotective Drugs Production Volume Share by Type (2018-2023)

    • Figure South China Neuroprotective Drugs Production Volume Share by Type (2018-2023)

    • Table South China Neuroprotective Drugs Sales Volume by Application (2018-2023)

    • Table South China Neuroprotective Drugs Sales Volume Share by Application (2018-2023)

    • Figure South China Neuroprotective Drugs Sales Volume Share by Application (2018-2023)

    • Table East China Neuroprotective Drugs Production Volume by Type (2018-2023)

    • Table East China Neuroprotective Drugs Production Volume Share by Type (2018-2023)

    • Figure East China Neuroprotective Drugs Production Volume Share by Type (2018-2023)

    • Table East China Neuroprotective Drugs Sales Volume by Application (2018-2023)

    • Table East China Neuroprotective Drugs Sales Volume Share by Application (2018-2023)

    • Figure East China Neuroprotective Drugs Sales Volume Share by Application (2018-2023)

    • Table Northeast China Neuroprotective Drugs Production Volume by Type (2018-2023)

    • Table Northeast China Neuroprotective Drugs Production Volume Share by Type (2018-2023)

    • Figure Northeast China Neuroprotective Drugs Production Volume Share by Type (2018-2023)

    • Table Northeast China Neuroprotective Drugs Sales Volume by Application (2018-2023)

    • Table Northeast China Neuroprotective Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Neuroprotective Drugs Sales Volume Share by Application (2018-2023)

    • Table Southwest China Neuroprotective Drugs Production Volume by Type (2018-2023)

    • Table Southwest China Neuroprotective Drugs Production Volume Share by Type (2018-2023)

    • Figure Southwest China Neuroprotective Drugs Production Volume Share by Type (2018-2023)

    • Table Southwest China Neuroprotective Drugs Sales Volume by Application (2018-2023)

    • Table Southwest China Neuroprotective Drugs Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Neuroprotective Drugs Sales Volume Share by Application (2018-2023)

    • Table Northwest China Neuroprotective Drugs Production Volume by Type (2018-2023)

    • Table Northwest China Neuroprotective Drugs Production Volume Share by Type (2018-2023)

    • Figure Northwest China Neuroprotective Drugs Production Volume Share by Type (2018-2023)

    • Table Northwest China Neuroprotective Drugs Sales Volume by Application (2018-2023)

    • Table Northwest China Neuroprotective Drugs Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Neuroprotective Drugs Sales Volume Share by Application (2018-2023)

    • Table NeuroVive Pharmaceutical (Sweden) Company Profile

    • Table NeuroVive Pharmaceutical (Sweden) Neuroprotective Drugs Revenue, Price and Gross (2018-2023)

    • Table Ceregene (USA) Company Profile

    • Table Ceregene (USA) Neuroprotective Drugs Revenue, Price and Gross (2018-2023)

    • Table Neuren Pharmaceuticals (Australia) Company Profile

    • Table Neuren Pharmaceuticals (Australia) Neuroprotective Drugs Revenue, Price and Gross (2018-2023)

    • Table Genervon Biopharmaceuticals (Canada) Company Profile

    • Table Genervon Biopharmaceuticals (Canada) Neuroprotective Drugs Revenue, Price and Gross (2018-2023)

    • Table Allon therapeutics (Canada) Company Profile

    • Table Allon therapeutics (Canada) Neuroprotective Drugs Revenue, Price and Gross (2018-2023)

    • Table Bionure Inc (USA) Company Profile

    • Table Bionure Inc (USA) Neuroprotective Drugs Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US